AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 1.895
-0.125 (-6.19%)
At close: Feb 26, 2026
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 217.76 million as of February 26, 2026. Its market cap has increased by 108.13% in one year.
Market Cap
217.76M
Enterprise Value
161.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.90
Market Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has decreased from 415.42M to 217.76M, a decrease of -47.58%. That is a compound annual growth rate of -8.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 217.76M | -5.25% |
| Dec 30, 2025 | 229.83M | 126.34% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 309.66M |
| Lipum AB | 303.34M |
| Bio-Works Technologies AB | 294.30M |
| Mendus AB | 292.02M |
| Isofol Medical AB | 245.97M |
| Xintela AB | 234.26M |
| Sprint Bioscience AB | 220.53M |
| Initiator Pharma | 212.20M |